Delivery Order SPE2DR25D3108-SPE2DR26F1PVR
Award Date 12/12/25
Potential Completion Date 12/15/25
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $61,157.01 delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen injectors on November 24, 2025, with an ultimate completion date of November 25, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a tirzepatide injection used for diabetes management, reflecting the company's...
- The Defense Logistics Agency awarded a delivery order valued at $4,616.23 to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 mL pen injections on December 9, 2025, with completion scheduled for December 10, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a tirzepatide-based medication used for diabetes management, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $30,465.45 for Mounjaro 5 mg/0.5 ml pen injections on December 10, 2025, with a completion date of December 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a tirzepatide-based pharmaceutical used for diabetes management, consistent with...
- The Defense Logistics Agency awarded a delivery order valued at $44,586.36 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 ml pen injectors on September 29, 2025. This is a firm fixed-price, non-set-aside contract with a completion date of September 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a tirzepatide-based diabetes medication used for glycemic control in patients with type 2 diabetes. This...
- The Defense Logistics Agency awarded a $4,123.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injections on December 10, 2025, with completion due by December 11, 2025. This non-set-aside competitive award was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a $5,060.48 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injections with a completion deadline of December 2, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX,...
- The Defense Logistics Agency awarded a $2,777.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injectors on September 8, 2025, with completion targeted for September 9, 2025. This delivery order, issued without a set-aside designation, represents a competitive award under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a $14,358.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen injections on December 1, 2025, with completion expected by December 2, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, consistent with AmerisourceBergen's...
- The Defense Logistics Agency awarded a $8,276.01 delivery order to AmerisourceBergen Drug Corp for Mounjaro 12.5 mg/0.5 ml pen injections on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control in patients with type 2 diabetes. This...
- The Defense Logistics Agency awarded a $19,091.85 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors with an ultimate completion date of September 8, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The pharmaceutical distributor,...